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A B S T R A C T
Purpose: To investigate eye closure sensitivity (ECS) in the EEGs of patients diagnosed with juvenile
myoclonic epilepsy (JME) and its relationship to prognosis.
Methods: We included 76 JME patients with a minimum follow-up of one year and evaluated a total of
254 EEGs to obtain evidence of ECS. The patients were grouped according to their response to treatment,
and these subgroups were compared in relation to ECS and other clinical and EEG features.
Results: There were 12 patients (15.8%) with poor prognosis who showed resistance to appropriate anti-
epileptic drug treatment, 15 (19.7%) patients with pseudo-resistance, and 49 (64.5%) patients with good
prognosis. The EEGs of only four of the patients displayed pure ECS (5.3%), and only one of these exhibited
poor prognosis. Furthermore, 11 patients (14.5%) had both ECS and photosensitivity, and two of these
patients exhibited poor prognosis. Thus, neither pure ECS nor ECS with photosensitivity correlated with
poor prognosis. A family history of epilepsy and focal ﬁndings on the EEG was correlated with poorer
prognosis.
Conclusions: ECS is a rare EEG ﬁnding in JME and does not appear to be a marker for poor prognosis.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Eye closure sensitivity (ECS) is a unique EEG phenomenon that
is described as the non-incidental appearance of transient epileptic
abnormalities following the closure of the eyes for 1–4 s during a
routine EEG recording.1 The underlying mechanism of ECS has not
yet been clariﬁed, and this phenomenon can be observed both in
idiopathic focal and generalized epilepsies. Idiopathic photosensi-
tive occipital lobe epilepsy is a typical example of syndromes
displaying ECS with focal epilepsy, and focal occipital epileptic
activity can be observed just after eye closure in this syndrome.2,3
Generalized forms of ECS have also been recorded in most of the
genetic/idiopathic generalized epilepsy (IGE) syndromes, such as
childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE),
and juvenile myoclonic epilepsy (JME), in addition to the proposed
syndrome known as eyelid myoclonia with absences (EMA), in* Corresponding author at: Bakirkoy Research and Training Hospital for
Psychiatry, Neurology, Neurosurgery, Department of Neurology, Istanbul Zuhur-
atbaba-Bakırkoy, 34147 Istanbul, Turkey. Tel.: +90 5327848273.
E-mail address: bguveli@hotmail.com (B. Tekin Gu¨veli).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.07.008which ECS plays a diagnostic role.4–8 It is well-known that EMA has
poorer prognosis compared with other absence epilepsies, and ECS
appears to be a poor prognostic marker for absence epilepsies.
In contrast, JME is a frequent IGE syndrome that exhibits good
response to treatment in the vast majority of patients. However,
there is a subgroup of JME patients that exhibit drug resistance.9–11
Although a number of the recent studies have investigated the
prognostic markers in JME, most of these did not report the effects
of ECS.12–14
Our aim was to investigate ECS in JME and its association with
prognosis and other clinical features.
2. Methods
We included 76 consecutive patients diagnosed with JME
according to the ILAE criteria who had at least one year of follow-
up and detailed EEG records available for the re-evaluation of
ECS.15,16 JME was diagnosed as a speciﬁc electroclinical syndrome
with bilateral, single or repetitive, arrhythmic, irregular myoclonic
jerks predominantly in the arms starting at puberty, and this
symptom might be combined with generalized tonic clonic
seizures (GTCS) or absence seizures. The EEG should show rapidvier Ltd. All rights reserved.
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according to the criteria for ECS.15,16
The data on gender, age at onset of epilepsy, seizure types,
febrile seizures, consanguinity, family history of epilepsy, response
to anti-epileptic drugs (AEDs), comorbid conditions, MRI ﬁndings,
and follow-up duration were retrospectively recorded in a
standardized form. Although an MRI was not mandatory for the
diagnosis, all of the patients had at least one CT.
Patients experiencing more than one GTCS per year and/or
more than ﬁve myoclonic or absence seizures/clusters per month
despite the regular use of appropriately high doses of syndrome-
speciﬁc AEDs were classiﬁed as the ‘‘poor prognosis’’ group (Group
I). Patients who exhibited a similar seizure frequency but who
irregularly used AEDs or experienced lifestyle problems were
grouped into the ‘‘pseudo-resistant’’ group (Group II), and the
remaining patients constituted the ‘‘good prognosis’’ group (Group
III).17 The prognosis was evaluated only if the duration of effective
therapy lasted more than 12 months.
For the EEG recordings, the electrodes were placed according to
the international 10–20 system, and both bipolar and referential
montages were used during the evaluations. The patients were
instructed to close and open their eyes at least seven times during
each EEG recording. Hyperventilation and intermittent photic
stimulation (IPS) were also used as standard activation procedures.
Our IPS protocol started with the eyes open for 5 s and was
followed by the eyes closed for 5 s; stimulus trains of 5–10–15–
20–25–30–35 Hz were administered as described elsewhere.18 All
of the available EEG traces were re-evaluated retrospectively by
two investigators, and consensus was reached in a joint session
when needed.
Generalized spike- or multispike-wave discharges in the resting
EEG that appeared on at least two occasions after eye closure
(excluding the IPS period) were accepted as ECS. Focal spikes/sharp
waves or recurrent 2- to 7-Hz localized slow wave paroxysms were
interpreted as a focal abnormality. Spikes and sharp waves
representing epileptic abnormalities of variable amplitudes were
clearly differentiated from the background rhythms and lasted 20–
70 ms and 70–200 ms, respectively. Photoparoxysmal responseTable 1
Clinical and EEG features of the study groups.
Group I
n:12 (15.8%)
Gender (Male/Female) 1/11 
Age at onset (year) 15.4  4 (7–25) 
Follow-up duration (year) 9.2  6 (2–24) 
Seizure types
Myoclonia + GTCS 7 (58.3%) 
Myoclonia + GTCS + Absences 2 (16.7%) 
Myoclonia + Absences 2 (16.7%) 
Myoclonia only 1 (8.3%) 
Psychiatric comorbidity
Depression 4 (33.3%) 
Anxiety disorder – 
Somatoform disorders 1 (8.3%) 
Febrile seizure history 4 (33.3%) 
Family history of epilepsy* 6 (50%) 
Consanguinity of parents 2 (17.6%) 
Clinical photosensitivity 3 (25%) 
ECS (+)/PPR(+) 2 (25%) 
ECS ()/PPR() 5 (41.6%) 
ECS (+)/PPR () – 
ECS ()/PPR(+) 5 (41.6%) 
Focal abnormality* 3(25%) 
Group I: poor prognosis group, Group II: pseudo-resistant group, Group III: good progno
Photoparoxysmal response.
P values reﬂected the comparison of Group I and III with Fisher exact test.
* p < 0.05.(PPR) was diagnosed if the EEG showed localized or generalized
spike, multi-spike, or spike-and-wave activities during IPS.
The continuous variables are expressed as the mean  SD,
whereas the categorical variables are presented as frequencies and
percentages. The Chi-square test was used to compare the differences
in the categorical variables between the groups. The SPSS 17.0
statistical software was used to perform the statistical analyses.
Differences with a p value of less than 0.05 were considered
statistically signiﬁcant.
3. Results
We included 24 males and 52 females with a diagnosis of JME,
and 49 of the total patients (64.5%) exhibited good prognosis
according to our criteria. Table 1 shows the clinical and EEG
ﬁndings in the study groups.
We noted that Group I included signiﬁcantly more patients with
a family history of epilepsy and focal EEG abnormalities. These
focal abnormalities were observed in 40% of the patients in the
poor prognosis group (Group I), and these were located mostly in
the anterior regions (frontotemporal (3 patients), frontal (2), and
central (1)). In contrast, only 4% of the patients in the therapy-
responsive group (Group III; frontotemporal (1) and centroparietal
(1)) exhibited focal abnormalities.
Of the 72 patients with MRI data, 62 (81.6%) had normal
ﬁndings. The abnormal MRI ﬁndings, which did not differ between
the groups, were the following: cerebral atrophy (3 patients),
cerebral atrophy and ventricular dilatation (2), pituitary micro-
adenoma (1), encephalomalacia (1), cerebellar hypoplasia (1),
meningioma (1), and non-speciﬁc hyperintense millimetric
lesions (1).
Most of the patients were using valproate (VPA) monotherapy
(50 patients) or VPA polytherapy (11) and rest of them were using
lamotrigine (4), levetiracetam (5), and topiramate (1) mono-
therapies and other combinations. However, ﬁve of the patients
did not use any drugs at the end of the study.
All of the patients had 3  2 (1–10) EEG recordings, and a total of
254 EEGs were re-analyzed for the purposes of this study. TheGroup II
n:15 (19.7%)
Group III
n:49 (64.5%)
P values
6/9 17/32 0.70
14.1  2 (12–18) 15.2  4 (6–31) 0.34
12.1  10 (1–30) 7.6  6 (1–23) 0.05
9 (60%) 36 (73.5%)
6 (40%) 9 (18.4%) 0.08
– 1 (2%)
– 3 (6.1%)
3 (20%) 5 (10.2%) 0.09
1(6.7%) 1 (2%)
1 (6.7%) 1 (2%)
2 (13.3%) 5 (10.2%) 1.00
10 (66.7%) 13 (26.5%) 0.005
1 (6.7%) 13 (26.5%) 0.15
4 (26.7%) 12 (24.5%) 0.55
2 (13.3%) 7 (14.2%)
7 (46.6%) 19 (38.7%) 0.89
1 (0.6%) 3 (0.6%)
5 (33.3%) 17 (34.6%)
6 (40%) 2 (4%) <0.000
sis group, ECS: eye closure sensitivity; GTCS: generalized tonic clonic seizure, PPR:
Fig. 1. This EEG example shows generalized multispike-wave discharges in the resting EEG that appear on more than two occasions after eye closure (excluding the IPS
period); these discharges were accepted as eye closure sensitivity in this female patient. She suffered myoclonic jerks since 14 years of age. Her seizures are under control with
500 mg/day VPA.
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among the groups is shown in Table 1 and exempliﬁed in Figs. 1 and 2.
There were 12 patients (15.8%) with poor prognosis who
showed resistance to appropriate anti-epileptic drug treatments,
15 (19.7%) patients with pseudo-resistance, and 49 (64.5%)
patients with good prognosis. The EEGs of only four of the patients
displayed pure ECS (5.3%), and only one of these patients had poor
prognosis. However, 11 (14.5%) of the patients had both ECS and
photosensitivity, and two of these had poor prognosis. Thus,
neither pure ECS nor ECS together with photosensitivity showed a
correlation with poor prognosis. The 49 patients in Group III were
seizure-free, but only 15 of these patients had normal EEGs in the
last follow-up (EEG abnormalities persisted in the remaining
cases).
Five females of the 15 patients with ECS described marked
eyelid blinking during daily life, but no typical seizures of eyelid
myoclonia could be recorded through video-EEG examinations. A
male patient who did not previously report eyelid myoclonia or
blinking was found to have mild eyelid myoclonia in IPS without
absences. In contrast, four patients exhibited typical generalized
myoclonia in IPS at the time of eye closure. Furthermore, one of
our patients reported two GTCSs during sunbathing when closing
her eyes.
Of the 15 patients with ECS at 19–36 years of age
(mean = 27.9), seven had normal EEGs and eight had continuing
ECS in their last EEG. Of the 37 patients with photosensitivity at
19–49 years of age (mean = 27.4), 16 still exhibited IPS
sensitivity in the last EEG.
4. Discussion
ECS can easily be overlooked when patients are not instructed
to close and open their eyes many times during routine EEG
recordings. The implications of this rare EEG phenomenon are not
known. Brigas et al. reported 11 patients with ECS, of which ﬁve
had CAE, three had JME, two had JAE, and one had epilepsy with
grand mal seizures upon awakening. These ﬁndings show that ECSis not syndrome-speciﬁc among the IGEs.6We previously analyzed
ECS in a prospective series and found the following result: of 10
patients with ECS, ﬁve had JME, two had absence epilepsies, and
three had EMA.5 In their retrospective analysis of 26 adult patients
with ECS, Sevgi et al. found that nine patients had idiopathic
occipital lobe epilepsy, one had JAE, four had nonspeciﬁc IGE, six
had JME, and six had EMA.4
EMA, which was ﬁrst described by Jeavons as a form of
photosensitive epilepsy, exhibits distinct clinical and EEG features
that justify its recognition as a separate epileptic syndrome
according to many reports.19–22 EMA can be deﬁned by the
following triad: (1) frequent occurrence of eyelid myoclonia with
or without brief absences related to generalized epileptic activity
and triggered by eye closure, (2) generalized photoparoxysmal EEG
response, often in combination with a history of visually induced
seizures, and (3) onset in childhood.21,22 Seizures occur mainly
after eye closures many times a day and are mostly resistant to
AEDs, and an eyelid myoclonic status epilepticus is reported in up
to one-ﬁfth of patients with this condition. Therefore, eye closure-
related discharges appear to be poor prognostic factors.20,22
In contrast, JME is a well-known syndrome with adolescent
onset that exhibits predominating myoclonia in addition to short
absences and GTCSs.23 It has been well established that most JME
patients respond well to AED, but recurrences are common after
drug withdrawal.23,24 There are some reports of JME patients with
drug resistance. The co-existence of all three seizure types is
consistently reported to be a risk factor for AED resistance in JME,
whereas myoclonus alone or a combination of absence seizures
and myoclonus are not.9,10,12,25–27 In addition to being an
important factor for pseudo-resistance, psychiatric comorbidity
is also a cited risk factor for true drug resistance.9,10,12 Personality
disorders and depression are frequently observed, which empha-
sizes the need to diagnose these in patients with JME.28,29 Our
results, which are shown in Table 1, are in line with the
abovementioned reports but do not reach statistical signiﬁcance.
It should be remembered, however, that our study design was
retrospective and based on a careful re-analysis of available EEGs.
Fig. 2. (a) This EEG shows the eye closure sensitivity of a 30-year-old female patient,
(b) an EEG showing generalized spikes and waves in the IPS just after eye closure
(same patient) and (c) an EEG showing prominent multispikes in the IPS after eye
closure (same patient).
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patients depending on the methodology.12,30 There are reports
claiming that focal ﬁndings indicate poor response to treatment of
JME, whereas other reports did not show any association.10–12 A
previous prospectively designed follow-up study conducted by our
group did not ﬁnd that focal epileptic ﬁndings are markers of poor
prognosis.12 However, our current study included focal recurrent
slow waves in the deﬁnition of focal abnormality and found anassociation with drug resistance. The retrospective nature of the
current study may result in a selection bias.
It was also interesting that the current study found that a family
history of epilepsy in all relatives or in only ﬁrst-degree relatives is
a marker for drug resistance in JME. Other studies that evaluated
family histories of epilepsy did not ﬁnd family history to be a
prognostic marker.11,24
Our results showed MRI abnormalities in 18.4% of the JME
patients. Abnormal MRI ﬁndings were reported in 12–21% of the
JME cases studied.31,32
It has been reported that ECS is present in 15–25% of the
patients with JME, which is similar to our results.10,33 The
relationship between ECS and the prognosis of JME has not been
investigated in the relevant literature, although it was reported as
an additional ﬁnding in two studies. A recent study from Brazil
evaluated the endophenotypes of 65 JME patients and suggested
that six JME patients with ECS showed signiﬁcantly poorer
responses to treatment.10 However, it should be noted that their
deﬁnition of drug response and methodology were different from
ours. In another study conducted in Turkey, ﬁve JME patients with
ECS were found to be seizure-free at the end of the follow-up
period.4 Thus, it is possible that genetic confounding factors may
be responsible for these contradictory results on the prognostic
effects of ECS in JME.
It has been suggested that EMA is not an infrequent condition
and constitutes 7.5% of the IGEs. In addition, this condition is likely
to be under-diagnosed due to its subtle clinical semiology, which
can be misinterpreted as tics or mannerisms, and to the masking of
EEG changes by the effects of age and AEDs.34,35 In some of our
patients, ECS was not previously diagnosed if the EEG was not
carefully analyzed and did not include repeated eye openings and
closings. Video EEG analysis is valuable for the diagnosis or
exclusion of eyelid myoclonia and related ECS.
Although these syndromes may show overlap in some cases,
JME and EMA could be distinguished based on the predominating
type and topography (generalized versus eyelid) of seizures and
age at onset.25 It could also be argued that there is an overlap
between EMA and JME in the patients with ECS analyzed in this
study. However, all of our patients reported the adolescent onset of
prominent myoclonic jerks as the predominating seizure type.
Reports of eyelid blinking in daily life could not be correlated with
ECS in the EEG in almost all of these cases, whereas generalized
jerks in the IPS were reported. Therefore, we consider that these
patients still should be categorized diagnosed with JME.
Photosensitivity appears at puberty and was reported to
disappear at approximately 24 years of age.36 Our retrospective
study suggested that both photosensitivity and ECS may persist in
the 3rd decade in some JME patients. We were unable to observe
any speciﬁc drug effect on photosensitivity or ECS in this study.
Electroclinical studies, such as those performed in our study,
disclosed prominent but incomplete overlap of photosensitivity
with ECS; hence, it has been suggested that the mechanisms
underlying ECS and photosensitivity may be different but correlat-
ed.34 However, the exact causes are not known. Data on reﬂex traits
suggest that ECS and photosensitivity are expressions of hyperex-
citability in JME.10 The role of the occipital cortex in photosensitive
epilepsies is of crucial importance; thus, both eye closures and
photosensitivity may synchronize neurons in the occipital cortex
depending on many other factors, such as light intensity, volume of
cortex activated, level of excitability, and spreading patterns.21
5. Conclusions
ECS is observed in approximately 1 out of 5 JME patients. We
were unable to show any relationship between ECS and poor
prognosis in JME patients. The mechanism of ECS is not known, and
B. Tekin Gu¨veli et al. / Seizure 22 (2013) 867–871 871this intriguing EEG ﬁnding should be included in future investiga-
tions of JME patients to elucidate its unknown implications.
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